nkg2dl (Bio-Techne corporation)
Structured Review
Nkg2dl, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 24 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lfm-a13/LFM-A13/ppr0769886-94-32-53
Average 93 stars, based on 24 article reviews
Images
Related Articles
Recombinant:Article Title: Staphylococcus aureus toxins mediate endothelial Thrombomodulin release during severe invasive infections Article Snippet: supernatants from strains M37 or P08 (7,000 ng/mL protein), (iii) 50 ng/mL recombinant α-toxin (IBT Bioservices, 1401–002), and (iv) co-treatment with Control:Article Title: Staphylococcus aureus toxins mediate endothelial Thrombomodulin release during severe invasive infections Article Snippet: supernatants from strains M37 or P08 (7,000 ng/mL protein), (iii) 50 ng/mL recombinant α-toxin (IBT Bioservices, 1401–002), and (iv) co-treatment with Infection:Article Title: Staphylococcus aureus toxins mediate endothelial Thrombomodulin release during severe invasive infections Article Snippet: supernatants from strains M37 or P08 (7,000 ng/mL protein), (iii) 50 ng/mL recombinant α-toxin (IBT Bioservices, 1401–002), and (iv) co-treatment with Negative Control:Article Title: Staphylococcus aureus toxins mediate endothelial Thrombomodulin release during severe invasive infections Article Snippet: supernatants from strains M37 or P08 (7,000 ng/mL protein), (iii) 50 ng/mL recombinant α-toxin (IBT Bioservices, 1401–002), and (iv) co-treatment with Microelectrode Array:Article Title: Staphylococcus aureus toxins mediate endothelial Thrombomodulin release during severe invasive infections Article Snippet: supernatants from strains M37 or P08 (7,000 ng/mL protein), (iii) 50 ng/mL recombinant α-toxin (IBT Bioservices, 1401–002), and (iv) co-treatment with Enzyme-linked Immunosorbent Assay:Article Title: Staphylococcus aureus toxins mediate endothelial Thrombomodulin release during severe invasive infections Article Snippet: supernatants from strains M37 or P08 (7,000 ng/mL protein), (iii) 50 ng/mL recombinant α-toxin (IBT Bioservices, 1401–002), and (iv) co-treatment with |
